{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:40:12Z","timestamp":1791222012688,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,12]]},"DOI":"10.7759\/cureus.92162","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T17:31:34Z","timestamp":1757698294000},"source":"Crossref","is-referenced-by-count":1,"title":["Aggressive Systemic Mastocytosis Presenting as Pyrexia of Unknown Origin and Sclerotic Bone Lesions: An Uncommon Presentation of a Rare Haematological Disorder"],"prefix":"10.7759","author":[{"given":"Umar","family":"Ismail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syeda Ambreen","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1159\/000504099","article-title":"The spectrum of aggressive mastocytosis: a workshop report and literature review","volume":"87","author":"Leguit R","year":"2020","unstructured":"Leguit R, Hebeda K, Kremer M, van der Walt J, Gianelli U, Tzankov A, Orazi A. The spectrum of aggressive mastocytosis: a workshop report and literature review. Pathobiology. 2020, 87:2-19. 10.1159\/000504099","journal-title":"Pathobiology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002068","article-title":"Mutation D816V alters the internal structure and dynamics of c-KIT receptor cytoplasmic region: implications for dimerization and activation mechanisms","volume":"7","author":"Laine E","year":"2011","unstructured":"Laine E, Chauvot de Beauch\u00eane I, Perahia D, Auclair C, Tchertanov L. Mutation D816V alters the internal structure and dynamics of c-KIT receptor cytoplasmic region: implications for dimerization and activation mechanisms. PLoS Comput Biol. 2011, 7:e1002068. 10.1371\/journal.pcbi.1002068","journal-title":"PLoS Comput Biol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000646","article-title":"Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal","volume":"5","author":"Valent P","year":"2021","unstructured":"Valent P, Akin C, Hartmann K, et al.. Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal. Hemasphere. 2021, 5:e646. 10.1097\/HS9.0000000000000646","journal-title":"Hemasphere"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12916","article-title":"Epidemiology of systemic mastocytosis in Denmark","volume":"166","author":"Cohen SS","year":"2014","unstructured":"Cohen SS, Skovbo S, Vestergaard H, et al.. Epidemiology of systemic mastocytosis in Denmark. Br J Haematol. 2014, 166:521-8. 10.1111\/bjh.12916","journal-title":"Br J Haematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12410","article-title":"Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease","volume":"279","author":"G\u00fclen T","year":"2016","unstructured":"G\u00fclen T, H\u00e4gglund H, Dahl\u00e9n B, Nilsson G. Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease. J Intern Med. 2016, 279:211-28. 10.1111\/joim.12410","journal-title":"J Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/cea.70101","article-title":"Patient-reported outcomes and provider perceptions of systemic mastocytosis: results from the PRISM study","author":"Triggiani M","year":"2025","unstructured":"Triggiani M, Hobart J, Alvarez-Twose I, et al.. Patient-reported outcomes and provider perceptions of systemic mastocytosis: results from the PRISM study. Clin Exp Allergy. 2025, 10.1111\/cea.70101","journal-title":"Clin Exp Allergy"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2340\/1651-226X.2024.31406","article-title":"Epidemiology of mastocytosis: a population-based study (Sweden)","volume":"63","author":"Bergstr\u00f6m A","year":"2024","unstructured":"Bergstr\u00f6m A, H\u00e4gglund H, Berglund A, Nilsson G, Lambe M. Epidemiology of mastocytosis: a population-based study (Sweden). Acta Oncol. 2024, 63:44-50. 10.2340\/1651-226X.2024.31406","journal-title":"Acta Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2016.01.005","article-title":"Systemic mastocytosis: a cohort study on clinical characteristics of 136 patients in a large tertiary centre","volume":"30","author":"Hermans MA","year":"2016","unstructured":"Hermans MA, Rietveld MJ, van Laar JA, et al.. Systemic mastocytosis: a cohort study on clinical characteristics of 136 patients in a large tertiary centre. Eur J Intern Med. 2016, 30:25-30. 10.1016\/j.ejim.2016.01.005","journal-title":"Eur J Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacig.2024.100316","article-title":"MASTering systemic mastocytosis: lessons learned from a large patient cohort","volume":"3","author":"Tse KY","year":"2024","unstructured":"Tse KY, Chen W, Puttock EJ, et al.. MASTering systemic mastocytosis: lessons learned from a large patient cohort. J Allergy Clin Immunol Glob. 2024, 3:100316. 10.1016\/j.jacig.2024.100316","journal-title":"J Allergy Clin Immunol Glob"},{"key":"ref10","article-title":"Regulation of normal and neoplastic human mast cell development in mastocytosis","volume":"116","author":"Metcalfe DD","year":"2005","unstructured":"Metcalfe DD. Regulation of normal and neoplastic human mast cell development in mastocytosis. Trans Am Clin Climatol Assoc. 2005, 116:185-204.","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10459-009-9182-2","article-title":"Clinical cognition and diagnostic error: applications of a dual process model of reasoning","volume":"14 Suppl 1","author":"Croskerry P","year":"2009","unstructured":"Croskerry P. Clinical cognition and diagnostic error: applications of a dual process model of reasoning. Adv Health Sci Educ Theory Pract. 2009, 14 Suppl 1:27-35. 10.1007\/s10459-009-9182-2","journal-title":"Adv Health Sci Educ Theory Pract"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22177","article-title":"Evaluation and classification of mast cell disorders: a difficult to manage pathology in clinical practice","volume":"14","author":"Leru PM","year":"2022","unstructured":"Leru PM. Evaluation and classification of mast cell disorders: a difficult to manage pathology in clinical practice. Cureus. 2022, 14:e22177. 10.7759\/cureus.22177","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.396.396","article-title":"Prognostic factors and survival prediction in 1,088 patients with mastocytosis collected in the registry of the European competence network on mastocytosis (ECNM Registry)","volume":"128","author":"Sperr WR","year":"2016","unstructured":"Sperr WR, Kundi M, Elberink HO, et al.. Prognostic factors and survival prediction in 1,088 patients with mastocytosis collected in the registry of the European competence network on mastocytosis (ECNM Registry). Blood. 2016, 128:396. 10.1182\/blood.V128.22.396.396","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/all.16132","article-title":"Prevalence of hypersensitivity reactions in various forms of mastocytosis: a pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry","volume":"79","author":"Niedoszytko M","year":"2024","unstructured":"Niedoszytko M, Gorska A, Brockow K, et al.. Prevalence of hypersensitivity reactions in various forms of mastocytosis: a pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry. Allergy. 2024, 79:2470-81. 10.1111\/all.16132","journal-title":"Allergy"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-229967","article-title":"Systemic mastocytosis: variable manifestations can lead to a challenging diagnostic process","volume":"12","author":"Nallamilli S","year":"2019","unstructured":"Nallamilli S, O'Neill A, Wilson A, Sekhar M, Lambert J. Systemic mastocytosis: variable manifestations can lead to a challenging diagnostic process. BMJ Case Rep. 2019, 12:10.1136\/bcr-2019-229967","journal-title":"BMJ Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.32135","article-title":"A rare case of aggressive systemic mastocytosis with skeletal osteosclerotic lesions on presentation: a diagnostic conundrum","volume":"14","author":"Ghorpade R","year":"2022","unstructured":"Ghorpade R, Tissavirasingham F, Vennepureddy A. A rare case of aggressive systemic mastocytosis with skeletal osteosclerotic lesions on presentation: a diagnostic conundrum. Cureus. 2022, 14:e32135. 10.7759\/cureus.32135","journal-title":"Cureus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.3717","article-title":"A case of aggressive systemic mastocytosis with bulky lymphadenopathy showing response to midostaurin","volume":"9","author":"Scium\u00e8 M","year":"2021","unstructured":"Scium\u00e8 M, Serpenti F, Muratori S, et al.. A case of aggressive systemic mastocytosis with bulky lymphadenopathy showing response to midostaurin. Clin Case Rep. 2021, 9:978-82. 10.1002\/ccr3.3717","journal-title":"Clin Case Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.60161","article-title":"Beyond midostaurin: role of avapritinib in managing systemic mastocytosis","volume":"16","author":"Pokima N","year":"2024","unstructured":"Pokima N, Khattar G, Keesari PR, et al.. Beyond midostaurin: role of avapritinib in managing systemic mastocytosis. Cureus. 2024, 16:e60161. 10.7759\/cureus.60161","journal-title":"Cureus"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024012612","article-title":"Systemic mastocytosis: current status and challenges in 2024","volume":"9","author":"Ustun C","year":"2025","unstructured":"Ustun C, Keklik Karadag F, Linden MA, Valent P, Akin C. Systemic mastocytosis: current status and challenges in 2024. Blood Adv. 2025, 9:2048-62. 10.1182\/bloodadvances.2024012612","journal-title":"Blood Adv"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-015-3117-3","article-title":"FDG-PET\/CT findings in systemic mastocytosis: a French multicentre study","volume":"42","author":"Djelbani-Ahmed S","year":"2015","unstructured":"Djelbani-Ahmed S, Chandesris MO, Mekinian A, et al.. FDG-PET\/CT findings in systemic mastocytosis: a French multicentre study. Eur J Nucl Med Mol Imaging. 2015, 42:2013-20. 10.1007\/s00259-015-3117-3","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/398449-aggressive-systemic-mastocytosis-presenting-as-pyrexia-of-unknown-origin-and-sclerotic-bone-lesions-an-uncommon-presentation-of-a-rare-haematological-disorder","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T17:31:35Z","timestamp":1757698295000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/398449-aggressive-systemic-mastocytosis-presenting-as-pyrexia-of-unknown-origin-and-sclerotic-bone-lesions-an-uncommon-presentation-of-a-rare-haematological-disorder"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.92162","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,12]]}}}